IMC analysis revealed the recruitment of FoxP3+ T cells and mast cells colocalizing in some tumor regions that contained also reduced HLA-class I expression and CD8+GranzymeB+ cells and were in this manner consistent with the acquisition of resistance to anti-PD-1 ICI treatment. This evidence concerns the gene FOXP3 and neoplasm.